Sumitomo Dainippon Pharma Co Ltd R&D Meeting Transcript
We'd like to begin. Thank you for joining the R&D meeting with Sumitomo Dainippon Pharma. Just for your information, this meeting is being broadcasted live and is telephonic. Today's presenters are Mr. Nomura, President and CEO of the company; Dr. Kimura, who will be presenting Psychiatry & Neurology area and Regenerative Medicine & Cell Therapy; Dr. Koshiya, who will be presenting Oncology area. And from the United States, we have Dr. Kenneth Koblan, Chief Scientific Officer in Sunovion Pharmaceuticals. I'm [Higuchi], a moderator.
We will be using the slide deck we sent out via e-mail. This is the agenda. Mr. Nomura will present the overview at the introduction, followed by the presentation on Psychiatry & Neurology area and then Regenerative Medicine & Cell Therapy by Dr. Kimura, followed by the presentation on Oncology area by Dr. Koshiya, followed by the presentation on SEP-363856 by Dr. Koblan. We will have a Q&A session at the end of the meeting. We can take questions from those who are joining on the phone.
Without further ado, I'd like to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
